Manufacturing Infrastructure

Generix Laboratories Private Limited is a reliable global supplier of specialty pharmaceutical products, recognized for delivering quality-assured, regulatory-ready healthcare solutions. We focus on therapeutic categories that demand precision, stability, and compliance — including injectable, inhalation-based therapies, biosimilar, and biologicals. With a strong network of certified manufacturing partners and a deep understanding of international market expectations, we offer customized solutions for diverse regional demands.

Key Therapeutic Segments:

High-Quality Sterile Injectables Our injectable range spans across critical care, oncology, and specialty formulations, including both lyophilized powders and liquid vials. All products are manufactured in internationally certified sites (WHO-GMP, EU-GMP, US-FDA) and meet stringent global quality and documentation standards.
Inhalation Products (MDIs) We offer a comprehensive range of metered dose inhalers, including bronchodilators, steroids, and combination therapies, produced in facilities equipped with dedicated infrastructure for inhalation manufacturing and stability testing.
Biosimilars and Biological Products our biologics portfolio includes biosimilar Erythropoietin, Filgrastim, Insulin analogues, and monoclonal antibodies, along with plasma-derived therapies such as IVIG, Human Albumin, and Coagulation Factors. All are supported by regulatory documentation, clinical data, and validated cold chain protocols.
Temperature-Sensitive Product Handling we ensure safe and compliant transport of sensitive biologics through reliable cold chain systems, aligned with international guidelines for storage and distribution across geographies.